Co-occurring Fatigue and Lymphatic Pain Incrementally Aggravate Their Negative Effects on Activities of Daily Living, Emotional Distress, and Overall Health of Breast Cancer Patients

Mei R. Fu, Melissa McTernan, Jeanna M. Qiu, Christine Miaskowski, Yvette P. Conley, Eunjung Ko, Deborah Axelrod, Amber Guth, Tamara J. Somers, Lisa J. Wood, Yao WangIntegrative 2022 · DOI

TL;DR

This study reveals that breast cancer survivors experiencing both fatigue and lymphatic pain simultaneously suffer significantly worse outcomes in daily activities, emotional well-being, and overall health compared to those with only one symptom or neither. The findings underscore the critical need for interventions that address both fatigue and lymphatic pain in concert to improve the quality of life for these patients.

What Problem Does This Paper Address?

Breast cancer treatment, while improving survival rates, often leaves patients with debilitating long-term side effects, primarily fatigue and lymphatic pain. While research has explored the negative impacts of each symptom individually on quality of life, physical function, and survival, the synergistic effects of their co-occurrence have remained largely unexamined. This paper addresses the critical knowledge gap regarding how the combined presence of fatigue and lymphatic pain, beyond their individual effects, impacts breast cancer patients' daily functioning, emotional state, and overall health. Understanding these combined effects is crucial for developing more effective and targeted treatment strategies.

Methods

The researchers employed a cross-sectional, observational study design to investigate the problem. They enrolled 354 female breast cancer patients who had completed acute treatment more than three months prior and had no signs of metastatic disease or recurrence. To assess the key variables, they utilized validated and reliable instruments:

  • Fatigue: Assessed using the 4-item Vitality Subscale of the Short Form Health Survey (SF-36-VS).
  • Lymphatic Pain: Measured using the Breast Cancer and Lymphedema Symptom Experience Index (BCLE-SEI) Part I, which captures pain sensations and swelling in the affected upper limb.
  • Activities of Daily Living (ADLs): Evaluated using the ADLs subscale of the BCLE-SEI Part II.
  • Emotional Distress: Assessed using the emotional distress subscale of the BCLE-SEI Part II.
  • Overall Health: Measured using the General Health Subscale of the SF-36.

Patients were categorized into four groups based on their symptom experience: no symptoms, only lymphatic pain, only fatigue, and co-occurring fatigue and lymphatic pain. Statistical analyses included descriptive statistics, Kruskal-Wallis tests, and Chi-square tests for group comparisons. To examine the effects of co-occurring symptoms on outcomes, two-part multivariable regression models were used for ADLs and emotional distress (due to potential zero inflation), and ordinary least squares (OLS) regression for overall health. Potential demographic and clinical confounders were controlled for in the adjusted models.

Datasets

Not discussed in the paper. The study utilized self-report questionnaires and medical record reviews from the enrolled participants.

Key Insights and Ideas

  • Synergistic Impact: The most striking insight is that the combination of fatigue and lymphatic pain doesn't just add up their negative effects; it incrementally aggravates them. This suggests a complex interplay where the presence of both symptoms creates a more severe burden than either would alone.
  • ADLs and Emotional Distress Hit Hardest: The study found that co-occurring fatigue and lymphatic pain had a disproportionately large negative impact on patients' ability to perform daily activities and their emotional well-being. This highlights these two domains as particularly vulnerable to the combined symptom burden.
  • Fatigue Alone Less Impactful on ADLs: Interestingly, while fatigue is a significant symptom, the study found that only fatigue did not significantly predict impaired ADLs, whereas only lymphatic pain did. This suggests that when it comes to daily functioning, the presence of pain alongside fatigue is the critical factor.
  • BMI as a Confounder: Higher Body Mass Index (BMI) was identified as a significant factor associated with more impaired ADLs, and also linked to higher BMI in patients with co-occurring fatigue and lymphatic pain. This points to obesity as a potential contributor or exacerbating factor.
  • Younger Age and Distress: Younger age was associated with higher emotional distress, suggesting that younger breast cancer survivors may be more vulnerable to emotional challenges related to their symptoms.

Key Results

  • Prevalence: A substantial 66.4% of breast cancer patients experienced at least one of the symptoms (only lymphatic pain, co-occurring fatigue and lymphatic pain, or only fatigue).
  • ADLs Impairment: Patients with co-occurring fatigue and lymphatic pain had significantly higher odds (OR = 24.43) of having impaired ADLs compared to those with only lymphatic pain. They also experienced a 179% increase in impaired ADL scores compared to those with no symptoms.
  • Emotional Distress: Patients with co-occurring fatigue and lymphatic pain had substantially higher odds (OR = 26.52) of experiencing emotional distress compared to those with only lymphatic pain. Their emotional distress scores increased by 211% compared to the no-symptom group.
  • Overall Health: While co-occurring fatigue and lymphatic pain, as well as only fatigue, were associated with poorer overall health, the study noted that the impact on overall health was not as dramatically amplified as it was for ADLs and emotional distress. Patients with co-occurring fatigue and lymphatic pain showed a 34% decrease in overall health scores, and those with only fatigue showed a 33% decrease.

Limitations and Future Work

The authors acknowledge that the cross-sectional study design prevents them from establishing causality or observing changes over time. They also note that while they controlled for many confounders, further consideration of tumor-specific features and treatment modalities could provide a more nuanced understanding of risk.

Future work should focus on:

  • Investigating Underlying Mechanisms: Understanding the biological and psychological mechanisms that drive the synergistic interactions between fatigue and lymphatic pain.
  • Developing Targeted Interventions: Creating and testing interventions that specifically address both fatigue and lymphatic pain concurrently, rather than in isolation.
  • Exploring Inflammatory Pathways: Given that both symptoms are associated with increased inflammatory responses, future research should explore these physiological interactions.
  • Routine Assessment: The study highlights the need to incorporate assessments of both fatigue and lymphatic pain, and their combined impact, into routine clinical practice for breast cancer survivors.

Summary updated

Abstract

Fatigue and lymphatic pain affected 66.4% of breast cancer patients. Findings from this study suggest that co-occurring fatigue and lymphatic pain have negative effects on breast cancer patients' ADLs, emotional distress, and overall health. The synergistic interactions between fatigue and lymphatic pain incrementally aggravated their negative effects on ADLs and emotional distress. Findings of the study highlight the need to evaluate the underlying mechanisms for co-occurring fatigue and lymphatic pain and develop interventions that target both fatigue and lymphatic pain to improve breast cancer patients' the quality of life.
BibTeX
@inproceedings{fu2022co,
  author = {Mei R. Fu and Melissa McTernan and Jeanna M. Qiu and Christine Miaskowski and Yvette P. Conley and Eunjung Ko and Deborah Axelrod and Amber Guth and Tamara J. Somers and Lisa J. Wood and Yao Wang},
  title = {{Co-occurring Fatigue and Lymphatic Pain Incrementally Aggravate Their Negative Effects on Activities of Daily Living, Emotional Distress, and Overall Health of Breast Cancer Patients}},
  booktitle = {Integrative},
  year = {2022},
  doi = {10.1177/15347354221089605},
}
Figure